AzTrials
AzTrials

Carpal Tunnel Syndrome (CTS)NCT07707089

Evaluation of AI-Mouse Use in Patients With Hand and Wrist Conditions

A study testing AI-Assisted Computer Input System and Conventional Computer Mouse in people with Carpal Tunnel Syndrome (CTS) and Wounds and Injuries, Hands, run by Nazarbayev University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

People with hand and wrist conditions, such as carpal tunnel syndrome or hand injuries, often experience pain and discomfort when using a computer mouse. This study will evaluate a new artificial intelligence (AI)-assisted computer input system ("AI-mouse") designed to reduce the amount of hand movement needed during… Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
AI-Assisted Computer Input System and Conventional Computer Mouse
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
No sites listed yet
Study dates
Jul 2026to Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18-65 years
  • Diagnosis of a hand or wrist condition, including carpal tunnel syndrome or hand/wrist injury.
  • Receiving care at the Hand Surgery Department of the National Scientific Center of Traumatology and Orthopedics.
  • Medically stable and assessed by a study physician as able to safely perform light computer-based hand movements.
  • Able to understand the study procedures and provide written informed consent.
  • Normal or corrected-to-normal vision sufficient to complete computer-based tasks.

Who cannot join

  • Severe pain or acute symptoms that may be aggravated by computer task performance.
  • Postoperative restrictions limiting hand or wrist movement.
  • Severe motor impairment preventing completion of the study tasks.
  • Cognitive or neurological disorders that interfere with understanding study procedures or task performance.
  • Uncorrected visual impairment that interferes with computer use.
  • Any medical condition that, in the opinion of the study physician, would make participation unsafe.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Jose Berengueres, PhD contact

+7 778 358 18 26

jose.berengueres@nu.edu.kz

Dina Kalinina, MD contact

+77756238719

dina.kalinina@nu.edu.kz

About this study

People with hand and wrist conditions, such as carpal tunnel syndrome or hand injuries, often experience pain and discomfort when using a computer mouse. This study will evaluate a new artificial intelligence (AI)-assisted computer input system ("AI-mouse") designed to reduce the amount of hand movement needed during computer tasks. Participants will complete short computer-based tasks using both a conventional mouse and the AI-assisted system while researchers measure task performance, muscle activity using surface electromyography (EMG), and participants' ratings of pain, physical strain, and usability. The study aims to determine whether the AI-assisted system can reduce physical effort and muscle load while maintaining effective computer interaction. Findings may help improve accessible computer technologies and support the development of ergonomic tools for people with hand and wrist impairments.

Being tested
AI-Assisted Computer Input System, Conventional Computer Mouse
Medical subject headings
Carpal Tunnel Syndrome, Wounds and Injuries, Hand Injuries, Wrist Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI-Assisted Computer Input SystemDevice

    A non-invasive computer input system that uses artificial intelligence to predict the user's intended on-screen action. Instead of relying primarily on continuous cursor movement and mouse clicking, the system presents predicted actions that participants can preview, accept, or discard using minimal keyboard input. The intervention is designed to reduce repetitive hand movements during computer interaction while preserving user control. Participants complete standardized computer tasks using the system during a single study session lasting less than four minutes.

  • Conventional Computer MouseDevice

    A standard computer mouse used for conventional point-and-click interaction. Participants complete the same standardized computer tasks as in the experimental condition, allowing direct comparison of task performance, upper-limb muscle activity measured by surface electromyography (EMG), and participant-reported pain, physical strain, and usability.

Study groups in NCT07707089
Study groupRoleWhat they receive
Conventional MouseActive comparatorParticipants perform standardized computer pointing tasks using a conventional computer mouse. Performance (task completion time, error rate, throughput), surface electromyography (EMG) of upper-limb muscles, and participant-reported outcomes (pain, physical strain, and usability) are assessed during task completion.
Receives: Device: Conventional Computer Mouse
AI-Mouse (Preview-Accept-Discard [PAD] System)ExperimentalParticipants perform the same standardized computer tasks using the AI-Mouse, a predictive human-computer interaction system based on the Preview-Accept-Discard (PAD) paradigm. The system generates AI-assisted action suggestions that can be accepted or discarded using minimal keyboard input, reducing cursor movement. Performance, surface electromyography (EMG), and participant-reported outcomes (pain, physical strain, and usability) are assessed during task completion.
Receives: Device: AI-Assisted Computer Input System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. APDF90 surface electromyography (sEMG) amplitude

    90th percentile amplitude probability distribution function (APDF90) of the processed sEMG envelope recorded from selected upper-limb muscles during standardized computer tasks.

    Measured: Baseline (during each intervention condition on Day 1)

  2. Muscular rest time

    Percentage of task duration during which the processed sEMG envelope remained below the predefined muscular-rest threshold of 2 µV.

    Measured: Baseline (during each intervention condition on Day 1)

Secondary outcomes (5)
  1. Integrated squared dynamic acceleration

    Cumulative dynamic movement workload measured by tri-axial accelerometry and expressed as integrated squared dynamic acceleration (mG²·s).

    Measured: Baseline (during each intervention condition on Day 1)

  2. 90th percentile dynamic acceleration

    Peak dynamic movement intensity measured by tri-axial accelerometry and expressed as the 90th percentile of dynamic acceleration (mG).

    Measured: Baseline (during each intervention condition on Day 1)

  3. Task completion time

    Time required to complete the standardized computer task using the conventional mouse and the AI-assisted computer input system.

    Measured: Baseline (during each intervention condition on Day 1)

  4. Error rate

    Percentage of incorrect target selections during the standardized computer task

    Measured: Baseline (during each intervention condition on Day 1)

  5. Self-reported pain

    Participant-reported hand and wrist pain after completing each intervention condition, assessed using a numeric rating scale

    Measured: Immediately after each intervention condition on Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2026
  2. Study startJul 2026 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionOct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07707089
Sponsor's protocol ID
1220/02042026
Status last verified
Jul 2026
First submitted
30 Jun 2026
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing AI-Assisted Computer Input System and Conventional Computer Mouse in people with Carpal Tunnel Syndrome (CTS) and Wounds and Injuries, Hands, run by Nazarbayev University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jose Berengueres, PhD (+7 778 358 18 26, jose.berengueres@nu.edu.kz), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

APDF90 surface electromyography (sEMG) amplitude (time frame: Baseline (during each intervention condition on Day 1)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in